Parnassus Investments
ABBV icon

Parnassus Investments’s AbbVie ABBV Stock Holding History

Parnassus Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-880,000
Closed -$64M – 94
2019
Q2 		$64M Sell
880,000
-820,000
-48% -$64.5M 0.24% 71
2019
Q1 		$137M Buy
+1,700,000
New +$139M 0.54% 46

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Parnassus Investments's ABBV Position: Q3 2019 in Review

Parnassus Investments sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 880,000 shares — an estimated $64M sold.

Parnassus Investments first reported a position in ABBV in Q1 2019 and held it in 2 quarters. The position peaked at $137M in Q1 2019. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Parnassus Investments reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • Parnassus Investments sold 880,000 AbbVie shares in Q3 2019, an estimated $64M.
  • Parnassus Investments first reported a position in AbbVie in Q1 2019 and held it in 2 quarters.
  • Parnassus Investments's AbbVie position peaked at $137M in Q1 2019.
  • 2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Parnassus Investments's 13F filing for Q3 2019, filed 30 Oct 2019.